Alamar Biosciences, Inc. engages in developing a proteomic liquid biopsy platform and sells instruments, consumables & services for the early detection of diseases. Its products include ARGO HT system, NULISA assays for Immunology, neurology & oncology, NULISAqpcr custom assay development, technology access program and Alamar analysis solutions. The company was founded by Yuling Luo, Yiyuan Yin and Steve Chen in May 2018 and is headquartered in Fremont, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
222
Frequently Asked Questions
What is Market Cap of Alamar Biosciences Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Alamar Biosciences Inc. market cap is $1.61B.
What is the 52-week high for Alamar Biosciences Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Alamar Biosciences Inc. 52 week high is $27.20 as of May 09, 2026.
What is the 52-week low for Alamar Biosciences Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Alamar Biosciences Inc. 52 week low is $17.00 as of May 09, 2026.
What is Alamar Biosciences Inc. stock price today?
Alamar Biosciences Inc. stock price today is $23.96.
What was Alamar Biosciences Inc. stock price yesterday?
Alamar Biosciences Inc. stock price yesterday was $23.66.
What is the 50-day moving average of Alamar Biosciences Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Alamar Biosciences Inc. 50-day moving average is $23.82.
How many employees does Alamar Biosciences Inc. have?